SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Melis Coban, Levent Tasli, Sebahat Turgut, Seyma Özkan, Melek Tunç Ata, Fulya Akın, Association of Adipokines, Insulin Resistance, Hypertension and Dyslipidemia in Patients with Psoriasis Vulgaris, Annals of Dermatology, 2016, 28, 1, 74

    CrossRef

  2. 2
    Akihiko Asahina, Yoshinori Umezawa, Koichi Yanaba, Hidemi Nakagawa, Serum C-reactive protein levels in Japanese patients with psoriasis and psoriatic arthritis: Long-term differential effects of biologics, The Journal of Dermatology, 2016, 43, 2
  3. 3
    Oguz Dikbas, Mehmet Tosun, Cemal Bes, Sukru Burak Tonuk, Ozge Yilmaz Aksehirli, Mehmet Soy, Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity, International Journal of Rheumatic Diseases, 2016, 19, 1
  4. 4
    Savas Guzel, Gamze Erfan, Mustafa Kulac, Eda Celik Guzel, Volkan Kucukyalcin, Sule Kaya, Ali Riza Kiziler, Chemerin and calprotectin levels correlate with disease activity and inflammation markers in psoriasis vulgaris, Dermatologica Sinica, 2015, 33, 1, 1

    CrossRef

  5. 5
    Francesco Mariani, Luca Roncucci, Chemerin/chemR23 axis in inflammation onset and resolution, Inflammation Research, 2015, 64, 2, 85

    CrossRef

  6. 6
    Erkan Özcan, N. Işıl Saygun, Muhittin A. Serdar, Nezahat Kurt, Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation, Clinical Oral Investigations, 2015, 19, 4, 921

    CrossRef

  7. 7
    Paolo Gisondi, Arturo Galvan, Luca Idolazzi, Giampiero Girolomoni, Management of Moderate to Severe Psoriasis in Patients with Metabolic Comorbidities, Frontiers in Medicine, 2015, 2,

    CrossRef

  8. 8
    Kristina Eisinger, Sabrina Krautbauer, Reiner Wiest, Thomas S. Weiss, Christa Buechler, Reduced serum chemerin in patients with more severe liver cirrhosis, Experimental and Molecular Pathology, 2015, 98, 2, 208

    CrossRef

  9. 9
    Banu Boyuk, Eda C. Guzel, Hande Atalay, Savas Guzel, Levent C. Mutlu, Volkan Kucukyalçin, Relationship between plasma chemerin levels and disease severity in COPD patients, The Clinical Respiratory Journal, 2015, 9, 4
  10. 10
    S. Beygi, V. Lajevardi, R. Abedini, C-reactive protein in psoriasis: a review of the literature, Journal of the European Academy of Dermatology and Venereology, 2014, 28, 6
  11. 11
    Konstantinos N. Aronis, Ayse Sahin-Efe, John P. Chamberland, Avron Spiro, Pantel Vokonas, Christos S. Mantzoros, Chemerin levels as predictor of acute coronary events: A case–control study nested within the veterans affairs normative aging study, Metabolism, 2014, 63, 6, 760

    CrossRef

  12. 12
    L. Naldi, A. Conti, S. Cazzaniga, A. Patrizi, M. Pazzaglia, A. Lanzoni, L. Veneziano, G. Pellacani, Diet and physical exercise in psoriasis: a randomized controlled trial, British Journal of Dermatology, 2014, 170, 3
  13. 13
    Sarah Churton, Liza Brown, Thuzar M. Shin, Neil J. Korman, Does Treatment of Psoriasis Reduce the Risk of Cardiovascular Disease?, Drugs, 2014, 74, 2, 169

    CrossRef

  14. 14
    Chunhu Wang, William K.K. Wu, Xiaodong Liu, Kai-Fa To, Gong G. Chen, Jun Yu, Enders K.W. Ng, Increased serum chemerin level promotes cellular invasiveness in gastric cancer: A clinical and experimental study, Peptides, 2014, 51, 131

    CrossRef

  15. 15
    Jorge Romaní, Assumpta Caixàs, Victoria Ceperuelo-Mallafré, José Manuel Carrascosa, Miquel Ribera, Mercedes Rigla, Joan Vendrell, Jesús Luelmo, Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI, Archives of Dermatological Research, 2013, 305, 2, 105

    CrossRef

  16. 16
    Luigi Naldi, Risk Factors for Psoriasis, Current Dermatology Reports, 2013, 2, 1, 58

    CrossRef